• Please log in or register to access this feature.

Journal of Internal Medicine

Cover image for Vol. 273 Issue 2

February 2013

Volume 273, Issue 2

Pages 111–218

  1. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
    2. You have free access to this content
  2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
      VEGFA and tumour angiogenesis (pages 114–127)

      L. Claesson-Welsh and M. Welsh

      Article first published online: 19 JAN 2013 | DOI: 10.1111/joim.12019

  3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
  4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
      Class 3 semaphorins: physiological vascular normalizing agents for anti-cancer therapy (pages 138–155)

      G. Serini, F. Bussolino, F. Maione and E. Giraudo

      Article first published online: 19 JAN 2013 | DOI: 10.1111/joim.12017

  5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
  6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have full text access to this OnlineOpen article
      Genetically engineered T cells for the treatment of cancer (pages 166–181)

      M. Essand and A. S. I. Loskog

      Article first published online: 19 JAN 2013 | DOI: 10.1111/joim.12020

  7. EDITORIAL COMMENTS

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
    2. You have free access to this content
  8. ORIGINAL ARTICLES

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. You have free access to this content
      Myocardial infarction with normal coronary arteries is common and associated with normal findings on cardiovascular magnetic resonance imaging: results from the Stockholm Myocardial Infarction with Normal Coronaries study (pages 189–196)

      O. Collste, P. Sörensson, M. Frick, S. Agewall, M. Daniel, L. Henareh, C. Ekenbäck, L. Eurenius, C. Guiron, T. Jernberg, C. Hofman-Bang, K. Malmqvist, E. Nagy, H. Arheden and P. Tornvall

      Article first published online: 5 AUG 2012 | DOI: 10.1111/j.1365-2796.2012.02567.x

    2. You have free access to this content
      Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study (pages 197–204)

      O. Ahlehoff, L. Skov, G. Gislason, J. Lindhardsen, S. L. Kristensen, L. Iversen, S. Lasthein, R. Gniadecki, T. N. Dam, C. Torp-Pedersen and P. R. Hansen

      Article first published online: 11 OCT 2012 | DOI: 10.1111/j.1365-2796.2012.02593.x

    3. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality (pages 205–216)

      N. D. Mygind, K. Iversen, L. Køber, J. P. Goetze, H. Nielsen, S. Boesgaard, M. Bay, J. S. Johansen, O. W. Nielsen, V. Kirk and J. Kastrup

      Article first published online: 31 DEC 2012 | DOI: 10.1111/joim.12006

  9. LETTER TO THE EDITOR

    1. Top of page
    2. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    3. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    4. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    5. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    6. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    7. SYMPOSIUM: VASCULAR BIOLOGY, METABOLISM AND CANCER
    8. EDITORIAL COMMENTS
    9. ORIGINAL ARTICLES
    10. LETTER TO THE EDITOR
    1. Response to comment from Dr. Sloan: ‘Look what's going down’ (pages 217–218)

      R. P. Nolan, J. S. Floras, L. Ahmed, P. J. Harvey, N. Hiscock, H. Hendrickx and D. Talbot

      Article first published online: 18 OCT 2012 | DOI: 10.1111/j.1365-2796.2012.02590.x

SEARCH

SEARCH BY CITATION